These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7378496)
1. [Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Modification of pancreatic trypsin inhibitor by soluble polysaccharides activated by titanium tetrachloride]. Larionova NI; Kazanskaia NF; Sakharov IIu; Mitiushina GV Biokhimiia; 1980 Apr; 45(4):683-6. PubMed ID: 7378496 [TBL] [Abstract][Full Text] [Related]
2. [Soluble high molecular weight derivatives of pancreatic inhibitors. Kinetic-thermodynamic studies of inhibitors linked to differently charged matrices]. Larionova II; Kazanskaia NF; Sakharov IIu Biokhimiia; 1979 Feb; 44(2):350-8. PubMed ID: 35244 [TBL] [Abstract][Full Text] [Related]
3. [Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Effect of electrostatic interaction of protein with the carrier on covalent binding and some physico-chemical properties of modified preparations of pancreatic inhibitor]. Larionova NI; Kazanskaia NF; Sakharov IIu; Berezin IV Biokhimiia; 1979 Nov; 44(11):2033-8. PubMed ID: 546446 [TBL] [Abstract][Full Text] [Related]
4. [Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Isolation and properties of the inhibitor bound to carboxymethyl cellulose and diethylaminoethyl dextran]. Larionova NI; Kazanskaya NF; Sakharov IY Biokhimiia; 1978 May; 43(5):880-6. PubMed ID: 656509 [TBL] [Abstract][Full Text] [Related]
5. Structure-function relationship for Kunitz and Kazal type trypsin inhibitors. Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Antonini E Farmaco Sci; 1983 Dec; 38(12):978-97. PubMed ID: 6365586 [No Abstract] [Full Text] [Related]
6. [Soluble high molecular weight derivatives of trypsin pancreatic inhibitor. Isolation and properties of dextran-bound pancreatic inhibitor]. Larionova NI; Kazanskaia NF; Sakharov IIu Biokhimiia; 1977 Jul; 42(7):1237-43. PubMed ID: 20163 [TBL] [Abstract][Full Text] [Related]
7. [Covalent immobilization of the pancreatic trypsin inhibitor on a polymeric carrier]. Maklakova IA; Valueva TA; Kolosova GV; Valuev LI; Mosolov VV Prikl Biokhim Mikrobiol; 1983; 19(5):654-8. PubMed ID: 6417650 [TBL] [Abstract][Full Text] [Related]
8. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen. Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor. Ogawa M; Tsushima T; Ohba Y; Ogawa N; Tanaka S; Ishida M; Mori T Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):155-8. PubMed ID: 3909270 [TBL] [Abstract][Full Text] [Related]
10. Protein inhibitors of proteinases. Laskowski M; Kato I Annu Rev Biochem; 1980; 49():593-626. PubMed ID: 6996568 [No Abstract] [Full Text] [Related]
11. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes. Marks WH; Eddeland A; Ohlsson K Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356 [TBL] [Abstract][Full Text] [Related]
12. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen. Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of mechanisms acting against mammary carcinoma: pancreatic trypsin inhibitor. Hakim AA Klin Wochenschr; 1978 Aug; 56(15):767-77. PubMed ID: 682532 [No Abstract] [Full Text] [Related]
14. Effect of hydrophobization of basic pancreatic proteinase inhibitor on the inhibition of bovine trypsin and human leukocyte elastase. Malykh EV; Tyurina OP; Balabushevitch NG; Larionova NI Biochemistry (Mosc); 1998 Oct; 63(10):1119-21. PubMed ID: 9864442 [TBL] [Abstract][Full Text] [Related]
15. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells. Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966 [TBL] [Abstract][Full Text] [Related]
16. Studies on trypsin inhibitors. Part IX. Synthesis and trypsin inhibitory activity of the duopentacontapeptide corresponding to the amino acid sequence of porcine pancreatic secretory trypsin inhibitor II (Kazal). Tomatis R; Guarneri M; Guggi A; Salvadori S; Rocchi R Int J Pept Protein Res; 1979 Oct; 14(4):347-55. PubMed ID: 42625 [TBL] [Abstract][Full Text] [Related]
17. Effects of human and ovine pancreatic secretory trypsin inhibitors on the proliferation of normal human fibroblasts. Hamilton I; Reynolds GW; Scott GK; Sharfe N; Tse CA Biol Chem Hoppe Seyler; 1990 Jan; 371(1):79-83. PubMed ID: 2322422 [TBL] [Abstract][Full Text] [Related]